Browsing publications by Dr Luke Gaughan

Newcastle AuthorsTitleYear
Dr Kelly Coffey
Lynsey Rogerson
Claudia Ryan-Munden
Dhuha Alkharaif
Dr Jacqueline Stockley
et al.		The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover2013
Andrew Axon
Dr Felicity May
Dr Luke Gaughan
Professor Faith Williams
Professor Peter Blain CBE
et al.		Tartrazine and sunset yellow are xenoestrogens in a new screening assay to identify modulators of human oestrogen receptor transcriptional activity2012
Dr Luke Gaughan
Dr Stuart McCracken
Professor Craig Robson
Dr Steven Powell
FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth2011
Dr Prabhakar Rajan
Caroline Dalgliesh
Pip Carling
Dr Sushma Grellscheid
Dr Kelly Coffey
et al.		Identification of Novel Androgen-Regulated Pathways and mRNA Isoforms through Genome-Wide Exon-Specific Profiling of the LNCaP Transcriptome2011
Dr Luke Gaughan
Dr Jacqueline Stockley
Nan Wang
Dr Stuart McCracken
Dr Kelly Coffey
et al.		Regulation of the androgen receptor by SET9-mediated methylation2011
Dr Fadhel Shaheen
Pawel Znojek
Dr Ann Fisher
Professor Ruth Plummer
Dr Luke Gaughan
et al.		Targeting the DNA Double Strand Break Repair Machinery in Prostate Cancer2011
Dr Prabhakar Rajan
Dr Luke Gaughan
Caroline Dalgliesh
Dr Amira El-Sherif
Professor Craig Robson
et al.		Regulation of gene expression by the RNA-binding protein Sam68 in cancer2008
Dr Emma Clark
Dr Anne Coulson
Caroline Dalgliesh
Dr Prabhakar Rajan
Dr Rakesh Heer
et al.		The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer2008
Dr Prabhakar Rajan
Dr Luke Gaughan
Caroline Dalgliesh
Dr Amira El-Sherif
Professor Craig Robson
et al.		The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor2008
Dr Ian Logan
Dr Luke Gaughan
Dr Stuart McCracken
Dr Vasileia Sapountzi
Professor Hing Leung
et al.		Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer2006
12